Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
25%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
AGNG
84
HOLDINGS
16%
ALSO IN CANC
CANC
53
HOLDINGS
25%
ALSO IN AGNG
SECTOR DRIFT (AGNG minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in AGNG |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 3.6% | 4.8% | 3.6% |
|
MERCK & CO. INC. | 3.0% | 3.6% | 3.0% |
|
BRISTOL-MYERS SQUIBB CO | 3.0% | 3.3% | 3.0% |
 |
ASTRAZENECA PLC | 2.8% | 3.5% | 2.8% |
|
ABBVIE INC | 3.2% | 2.8% | 2.8% |
AGNG Overweight Relative to CANC
 |
NOVO NORDISK A/S-B | 3.8% |
|
EDWARDS LIFESCIENCES CORP | 3.4% |
 |
ROCHE HOLDING AG-BR | 3.2% |
|
VENTAS INC | 3.1% |
|
WELLTOWER, INC. | 3.1% |
 |
UCB SA | 2.9% |
|
STRYKER CORP | 2.8% |
|
SANDOZ GROUP AG | 2.6% |
 |
MEDTRONIC PLC | 2.6% |
|
BOSTON SCIENTIFIC CORP | 2.4% |
AGNG Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -7.1% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -4.2% |
|
COGENT BIOSCIENCES INC | -4.1% |
|
NOVARTIS AG | -4.1% |
|
IMMUNOME, INC. | -3.9% |
|
CELCUITY INC. | -3.6% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -3.5% |
|
NUVALENT, INC. CLASS A | -3.4% |
|
BRIDGEBIO PHARMA, INC. | -2.8% |
|
GENMAB A/S SPONSORED ADR | -2.4% |